Inhibition of L-Type Amino Acid Transporter Modulates the Expression of Cell Cycle Regulatory Factors in KB Oral Cancer Cells

• Published in: Biological & Pharmaceutical Bulletin 2010/07/01, Vol.33(7), pp.1117-1121
• Main Authors: Kim, Chun Sung, Moon, In-Sung, Park, Ju-Hyun, Shin, Woo-Cheol, Chun, Hong Sung, Lee, Sook-Young, Kook, Joong-Ki, Kim, Heung-Joong, Park, Joo-Cheol, Endou, Hitoshi, Kanai, Yoshikatsu, Lee, Byung-Kwon, Kim, Do Kyung
• Format: Article
• Language: English
• Subjects: 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid; Amino Acid Transport Systems - antagonists & inhibitors; Blotting, Western; cancer cell; Cell Cycle Proteins - physiology; cell cycle regulatory factor; Cell Line, Tumor; Humans; Immunoprecipitation; L-type amino acid transporter; Mouth Neoplasms - pathology
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.33.1117

The purpose of this study was to examine the effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), an inhibitor of L-type amino acid transporters, on the cell growth suppression in KB human oral cancer cells and to study the roles of cell cycle regulatory factors in the BCH-induced growth inhibition. The effect of BCH on cell growth suppression and the influence of BCH to cell cycle regulatory factors in KB cell growth inhibition were examined using cell cycle analysis, immunoblotting and immunoprecipitation. The BCH treatment induced cell cycle arrest at G1 phase in KB cells. The expression of cyclin D3 was remarkably decreased by BCH treatment. The BCH inhibited the expression of cyclin-dependent protein kinase 6 (CDK6) in a time-dependent manner. In addition, the expression of CDK inhibitor p27 was increased by BCH treatment in KB cells, but not CDK inhibitors p21 and p15. These results suggest that, in KB cells, the inhibition of LAT1 by BCH causes cell cycle arrest at G1 phase by inhibiting cyclin D3–CDK6 complex whereas increasing expression of a CDK inhibitor p27.